FDA warns Australias Delta Laboratories about CGMP violations in its production of finished pharmaceuticals.
Federal Register notice: FDA makes available a guidance entitled Unique Device Identification: Policy Regarding Compliance Dates for Class I and Uncla...
Federal Register notice: FDA announces a 5/22-23 public workshop on Accreditation Scheme for Conformity Assessment of Medical Devices to FDA-Recognize...
Federal Register notice: FDA proposes to delay the effective date of certain portions of a final rule that amended the agencys existing regulations de...
FDA starts a collaborative program with the Defense Department to prioritize development and approval of medical products needed by U.S. troops.
FDA warns Chinas Shanwei Honghui Daily Appliance Co. about CGMP violations in its manufacturing of finished pharmaceuticals.
An FDA drug safety alert says Tesaros Varubi (rolapitant) injectable emulsion has been associated with anaphylaxis and other serious hypersensitivity ...
FDA releases its latest batch of Warning Letters that includes Becton Dickinson, Delta Laboratories, Schrofner Cosmetics, Shanwei Honghui Daily Applia...